Remove 2014 Remove Biosimilars Remove Generic Medicine
article thumbnail

Waters, as a strategic partner to the pharma industry, can help India become a world leader in biosimilars

Express Pharma

The Food and Drug Administration (FDA) approved an average of 43 drugs in 2014-18, compared to an average of 23 in the first decade of the century. For decades, Waters has been a trusted partner to many pharma and generics companies operating in India, particularly for small molecule QA/QC. How poised are you to leverage them?

article thumbnail

Sandoz bulks up ahead of possible sale with Coalesce buy

pharmaphorum

Cambridge, UK-based Coalesce, first formed in 2009 primarily as a contract services business, changed direction in 2014 to develop its own, in-house inhaler technologies. The post Sandoz bulks up ahead of possible sale with Coalesce buy appeared first on.